Notably, endothelial cells acquire BCR-ABL RNA and the oncoprotein after incubation with EVs released from both K562 cells or the plasma of newly diagnosed CML patients [103]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.